Moleculin to Participate in Panel at ROTH Capital's "COVID-19 Therapeutics in Development"
Healthcare Event HOUSTON, Oct. 27, 2020 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company), a clinical...